D2G Oncology

D2G Oncology, Inc. is a biotechnology company focused on precision cancer therapeutics by relating drugs to genotypes. Founded in 2018 and headquartered in California, the company aims to transform cancer treatment through the use of genomic data. By tailoring oncology therapies to match the specific genotype of cancer patients, D2G Oncology enables healthcare institutions to provide more personalized and effective cancer treatments. This innovative approach seeks to improve patient outcomes and advance the field of oncology.